375 related articles for article (PubMed ID: 30968438)
21. Successful treatment of ulcerated infantile hemangioma with brimonidine-timolol cream: 2 cases report and review of the literature.
Almebayadh M
J Dermatolog Treat; 2020 Jun; 31(4):433-434. PubMed ID: 30973791
[TBL] [Abstract][Full Text] [Related]
22. Outpatient use of oral propranolol and topical timolol for infantile hemangiomas: survey results and comparison with propranolol consensus statement guidelines.
Kumar MG; Coughlin C; Bayliss SJ
Pediatr Dermatol; 2015; 32(2):171-9. PubMed ID: 25556828
[TBL] [Abstract][Full Text] [Related]
23. Doing the math: A simple approach to topical timolol dosing for infantile hemangiomas.
Dalla Costa R; Prindaville B; Wiss K
Pediatr Dermatol; 2018 Mar; 35(2):276-277. PubMed ID: 29315812
[TBL] [Abstract][Full Text] [Related]
24. A novel topical nano-propranolol for treatment of infantile hemangiomas.
Chen ZG; Zheng JW; Yuan ML; Zhang L; Yuan WE
Nanomedicine; 2015 Jul; 11(5):1109-15. PubMed ID: 25791814
[TBL] [Abstract][Full Text] [Related]
25. Propranolol therapy for infantile hemangioma: our experience.
Zhang L; Wu HW; Yuan W; Zheng JW
Drug Des Devel Ther; 2017; 11():1401-1408. PubMed ID: 28507428
[TBL] [Abstract][Full Text] [Related]
26. β-blocker therapy for infantile hemangioma.
Koh SP; Leadbitter P; Smithers F; Tan ST
Expert Rev Clin Pharmacol; 2020 Aug; 13(8):899-915. PubMed ID: 32662682
[TBL] [Abstract][Full Text] [Related]
27. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
J Cutan Med Surg; 2012; 16(5):317-23. PubMed ID: 22971306
[TBL] [Abstract][Full Text] [Related]
28. The Role of Topical Timolol in the Treatment of Infantile Hemangiomas: A Systematic Review and Meta-analysis.
Khan M; Boyce A; Prieto-Merino D; Svensson Å; Wedgeworth E; Flohr C
Acta Derm Venereol; 2017 Nov; 97(10):1167-1171. PubMed ID: 28421234
[TBL] [Abstract][Full Text] [Related]
29. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
J Cutan Med Surg; 2012; 16(2):115-21. PubMed ID: 22513064
[TBL] [Abstract][Full Text] [Related]
30. Enhanced Percutaneous Delivery of Beta-Blockers Using Thermal Resurfacing Drug Delivery System for Topical Treatment of Infantile Hemangiomas.
Mashiah J; Bar-Ilan E; Koren A; Friedman O; Zur E; Artzi O
Dermatology; 2020; 236(6):565-570. PubMed ID: 32653885
[TBL] [Abstract][Full Text] [Related]
31. Review of topical beta blockers as treatment for infantile hemangiomas.
Painter SL; Hildebrand GD
Surv Ophthalmol; 2016; 61(1):51-8. PubMed ID: 26408055
[TBL] [Abstract][Full Text] [Related]
32. Management of infantile hemangiomas-experience of a tertiary hospital.
Gomes R; Salazar L; Fraga C; Correia MR; Barbosa-Sequeira J; Fernandes A; Álvares S; Banquart Leitão J; Paiva Coelho M
Eur J Pediatr; 2023 Apr; 182(4):1611-1618. PubMed ID: 36705724
[TBL] [Abstract][Full Text] [Related]
33. Beta blocker treatment of infantile conjunctival hemangiomas--observations from 2 cases.
Chang TC; Estes R
J AAPOS; 2014 Feb; 18(1):80-2. PubMed ID: 24568991
[TBL] [Abstract][Full Text] [Related]
34. Topical timolol solution versus laser in treatment of infantile hemangioma: a comparative study.
Tawfik AA; Alsharnoubi J
Pediatr Dermatol; 2015; 32(3):369-76. PubMed ID: 25740672
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Two Formulations of Topical Timolol for the Treatment of Infantile Hemangiomas.
Ng MSY; Tay YK; Ng SS; Foong AYW; Koh MJ
Pediatr Dermatol; 2017 Jul; 34(4):492-493. PubMed ID: 28543755
[TBL] [Abstract][Full Text] [Related]
36. Spectral Doppler ultrasound for predicting long-term response to topical timolol in children with infantile hemangioma.
He L; Huang G
J Clin Ultrasound; 2017 Oct; 45(8):480-487. PubMed ID: 28369943
[TBL] [Abstract][Full Text] [Related]
37. Topical timolol maleate for superficial infantile hemangiomas: an observational study.
Xu DP; Cao RY; Tong S; Xue L; Sun NN; Wang XK
J Oral Maxillofac Surg; 2015 Jun; 73(6):1089-94. PubMed ID: 25843815
[TBL] [Abstract][Full Text] [Related]
38. Prospective, open-label, rater-blinded and self-controlled pilot study of the treatment of proliferating superficial infantile hemangiomas with 0.5% topical timolol cream versus 595-nm pulsed dye laser.
Ying H; Zou Y; Yu W; Qiu Y; Ma G; Chang L; Gu Y; Lyu D; Lin X
J Dermatol; 2017 Jun; 44(6):660-665. PubMed ID: 28191657
[TBL] [Abstract][Full Text] [Related]
39. Topical Timolol Maleate 0.5% for Infantile Hemangioma: Its Effectiveness Compared to Ultrapotent Topical Corticosteroids - A Single-Center Experience of 278 Cases.
Danarti R; Ariwibowo L; Radiono S; Budiyanto A
Dermatology; 2016; 232(5):566-571. PubMed ID: 27592104
[TBL] [Abstract][Full Text] [Related]
40. [A clinical study of Timolol Maleate Eye Drops for the treatment of superficial infantile hemangiomas].
Linjun Y; Jiachuan X; Baoli S; Qixing X; Chunfen L
Zhonghua Zheng Xing Wai Ke Za Zhi; 2015 Nov; 31(6):440-5. PubMed ID: 27055324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
